Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Embody vs Found
Embody and Found both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Embody
Ranked #47 for women · Grade B−
Luna Fit
Best for: Women who want the lowest possible entry cost without signing a prepay commitment, and who would rather chew a medicated gum than inject.
Visit EmbodyFound
Higher scoreRanked #9 for women · Grade B
Luna Fit
Best for: Women who have (or might qualify for) insurance that covers GLP-1s and want a marketplace that shops that benefit for them, or who'd rather take an oral pill (Rybelsus) than inject.
Visit FoundThe verdict for women
Found edges out Embody on the Luna Fit Score, 84 to 81 (B vs B−). Women who have (or might qualify for) insurance that covers GLP-1s and want a marketplace that shops that benefit for them, or who'd rather take an oral pill (Rybelsus) than inject. The reasoning behind that number is in the Found scorecard.
Embody is still a genuine option — the cheapest month-to-month price in the ranking by a wide margin, from a program that names all four of its compounding pharmacies — with the catch that it is a starting-dose promotional rate against a $299 list price, so it is the figure most likely to move. Weigh the six women's-health factors below against your own priorities; the Embody scorecard goes through each of them, and if neither of these two is the one, the Embody alternatives, scored on the same six factors widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Embody | Found |
|---|---|---|
| Luna Fit Score | 81/100 · B− | 84/100 · B |
| Overall rank | #47 | #9 |
| Semaglutide | $79/mo, no commitment (starting dose, promotional rate; $299 list) | $169/mo cash-pay (multi-month plan) — as low as $99/mo with qualifying insurance, or $289/mo cash-pay billed month-to-month; compounded, flat price at every dose (Found does not publish a separate semaglutide-specific rate) |
| Tirzepatide | $129/mo, no commitment (starting dose, promotional rate; $349 list) | $169/mo cash-pay (multi-month plan) — as low as $99/mo with qualifying insurance, or $289/mo cash-pay billed month-to-month; compounded, flat price at every dose (Found does not publish a separate tirzepatide-specific rate) |
| Coverage | 49 states (not Louisiana) | All 50 states (self-pay); insurance-plan availability varies by state — California showed no in-network insurance plans as of 2026-08-04 |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
Luna Fit
Embody
Ranked #47 · Grade B−
What we like
- $79/mo semaglutide and $129/mo tirzepatide with no commitment — the lowest month-to-month figures in this ranking
- Names all four partner pharmacies (RedRock, Health Warehouse, Precision Compounding and Triad Rx) rather than referring vaguely to 'a licensed pharmacy'
- LegitScript certified
The caveats
- $79 is a starting-dose promotional rate against a $299 list price its own store still records, so it is the figure in this ranking most likely to move — the $69 seen elsewhere is the 12-month prepay rate, not a second monthly offer
- Not available in Louisiana, and the main site does not state coverage at all
- Copy says 'flat at every dose' in one place and 'starting at $79' in another, with no published dose table to settle it
Luna Fit
Found
Ranked #9 · Grade B
What we like
- Insurance-based pricing can bring the real monthly cost to $99/mo, and eligible Medicare Part D members can get brand-name Wegovy, Zepbound or Foundayo for a flat $50/mo copay via Found's CMS GLP-1 Bridge program (through Dec 2027)
- One of the broadest medication catalogs in this ranking — 15+ named products including oral Rybelsus, injectable Wegovy, Zepbound, Ozempic, Mounjaro and Foundayo, plus compounded semaglutide and tirzepatide
- No lock-in on the subscription itself — cancel anytime per its own terms, effective within 24 hours
The caveats
- Compounded semaglutide and tirzepatide are not priced separately anywhere on the site — you get a plan-tier rate ($99–$289/mo depending on insurance and commitment), not a molecule-specific figure
- The lowest cash-pay rate ($169/mo) requires committing to a multi-month plan up front; paying month-to-month without insurance runs $289/mo
- Subscription fees are stated non-refundable in Found's own terms, with refunds granted only at its discretion
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Embody nor Found is only worth comparing with the other. Embody is also written up against CoreAge Rx, 12 points apart on the Luna Fit Score — see the Embody–CoreAge Rx head-to-head. Found is also written up against Eden, 4 points apart — see how Found and Eden compare on the Luna Fit Score.
- Embody vs CoreAge Rx
- Embody vs Enhance MD
- Embody vs Eden
- Found vs yourEra
- Found vs Sesame Care
- Found vs HealthRX
Or browse the full comparison hub.